by Karin Fleming | May 13, 2020
Like a shadow lengthening at sunset or a dark cloud slowly obscuring the sun, the novel coronavirus has the potential to spread silently before positive tests confirm diagnoses in people infected with the virus. To help get ahead of the curve and prepare Sutter’s...
by Karin Fleming | May 6, 2020
More than 20 million Americans suffer from chronic insomnia. This sleep disorder can cause emotional distress, impaired functioning and reduced quality of life. It can even contribute to an increased risk for other health problems such as depression and high blood...
by Karin Fleming | Apr 27, 2020
With experts predicting that a vaccine for COVID-19 is at least a year away, Sutter and Vitalant are collaborating to offer investigational treatment with convalescent plasma—blood plasma collected from people who have recovered from COVID-19—to hospitalized patients...
by Karin Fleming | Apr 20, 2020
To learn how Sutter cancer researchers are applying machine learning to cancer care, we interviewed John Chan, M.D., a gynecologic oncologist at Sutter’s California Pacific Medical Center (CPMC) and Palo Alto Medical Foundation, and the Denise & Prentis Cobb Hale...
by Karin Fleming | Apr 8, 2020
Not-for-profit Sutter Health Launches Clinical Trials with Gilead Sciences Sutter Health, together with health systems across Northern California has teamed up with Foster City-based Gilead Sciences on clinical trials for a promising treatment for COVID-19. The...
